Caprelsa Articles
Germany's IQWiG finds no proof of added benefit for AstraZeneca's Caprelsa in thyroid cancer
5 July 2012
EU approval for AstraZeneca thyroid cancer drug Caprelsa
21 February 2012
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
